Society of Gynecologic Oncology
Chicago, IL USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

SGO’s Foundation for Gynecologic Oncology Merges with Foundation for Women’s Cancer

Gynecologic oncology research, education and awareness took a historic step forward on Jan. 1, 2016, when the Society of Gynecologic Oncology’s Foundation for Gynecology Oncology and the Foundation for Women’s Cancer (FWC) became one foundation...
4-Jan-2016 3:05 PM EST Add to Favorites

Dr. Robert Coleman Begins SGO and Foundation Presidency


Robert L. Coleman, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, has started his one-year term as the 47th President of the Society of Gynecologic Oncology (SGO) and fifth President of the Foundation for Gynecologic Oncology.
10-Apr-2015 11:05 AM EDT Add to Favorites

Immunotherapy Delays Recurrence for Stage III and IV Ovarian Cancers

Personalized medicine is getting closer to reality for women with late-stage ovarian cancer. An experimental immunotherapy is in the works that can target an individual woman’s tumor and extend the time period between initial treatment and the...
27-Mar-2015 9:00 AM EDT Add to Favorites

Medical Societies Recommend Consideration of Primary HPV Testing for Cervical Cancer Screening

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing...
8-Jan-2015 1:00 AM EST Add to Favorites

FDA Approval of Nonavalent HPV Vaccine Adds New Tool to Eradicate Cervical Cancer

The Food and Drug Administration’s approval of a nonavalent vaccine against the human papillomavirus (HPV) represents another important step in the eradication of cervical cancer, according to the Society of Gynecologic Oncology (SGO).
10-Dec-2014 4:30 PM EST Add to Favorites

Primary HPV Screening Offers Important New Option for Cervical Cancer Detection, Prevention

The Society of Gynecologic Oncology (SGO) welcomes new options for detecting and preventing cervical cancer, including the primary human papillomavirus (HPV) testing recently approved by the FDA.
24-Apr-2014 2:00 PM EDT Add to Favorites

Targeted Cancer Therapy May Treat Resistant Gynecologic Cancers

Veliparib, an oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.
21-Mar-2014 9:30 AM EDT Add to Favorites

Women with BRCA1 Mutations May Still Be at Risk for Rare Types of Uterine Cancer After Preventive Surgery to Remove Ovaries, Fallopian Tubes

Women with BRCA1 mutations may have an increased risk for developing rare types of aggressive uterine cancer despite having their ovaries and fallopian tubes removed, suggest preliminary findings.
21-Mar-2014 10:15 AM EDT Add to Favorites

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.